These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12653696)

  • 1. Larval therapy--an effective method of ulcer debridement.
    Wolff H; Hansson C
    Clin Exp Dermatol; 2003 Mar; 28(2):134-7. PubMed ID: 12653696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers.
    Dumville JC; Worthy G; Soares MO; Bland JM; Cullum N; Dowson C; Iglesias C; McCaughan D; Mitchell JL; Nelson EA; Torgerson DJ;
    Health Technol Assess; 2009 Nov; 13(55):1-182, iii-iv. PubMed ID: 19925723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Larval therapy for leg ulcers (VenUS II): randomised controlled trial.
    Dumville JC; Worthy G; Bland JM; Cullum N; Dowson C; Iglesias C; Mitchell JL; Nelson EA; Soares MO; Torgerson DJ;
    BMJ; 2009 Mar; 338():b773. PubMed ID: 19304577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Wounds with different aetiology treated using larval debridement therapy: presentation of two cases].
    González-de Paz L; Fortes-Bordas M; de Pedro-Elvira B
    Enferm Clin; 2010; 20(1):47-53. PubMed ID: 20133176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of larval therapy for the debridement of leg ulcers: results of a multicenter, randomized, controlled, open, observer blind, parallel group study.
    Mudge E; Price P; Walkley N; Harding KG
    Wound Repair Regen; 2014; 22(1):43-51. PubMed ID: 24299513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rearing larvae of Lucilia sericata for chronic ulcer treatment--an improved method.
    Wolff H; Hansson C
    Acta Derm Venereol; 2005; 85(2):126-31. PubMed ID: 15823905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost effectiveness of larval therapy in venous ulcers.
    Wayman J; Nirojogi V; Walker A; Sowinski A; Walker MA
    J Tissue Viability; 2000 Jul; 10(3):91-4. PubMed ID: 11299572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of a diabetic foot ulcer using larval therapy.
    Knowles A; Findlow A; Jackson N
    Nurs Stand; 2001 Oct 24-30; 16(6):73-6. PubMed ID: 11977731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Larval Therapy for Chronic Cutaneous Ulcers: Historical Review and Future Perspectives.
    Raposio E; Bortolini S; Maistrello L; Grasso DA
    Wounds; 2017 Dec; 29(12):367-373. PubMed ID: 29324424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Maggot therapy in wound management].
    Falch BM; de Weerd L; Sundsfjord A
    Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1864-7. PubMed ID: 19844278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient acceptability of larval therapy for leg ulcer treatment: a randomised survey to inform the sample size calculation of a randomised trial.
    Petherick ES; O'Meara S; Spilsbury K; Iglesias CP; Nelson EA; Torgerson DJ
    BMC Med Res Methodol; 2006 Sep; 6():43. PubMed ID: 16948837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of maggot debridement therapy for tropical diabetic hand syndrome.
    Jiang KC; Luo N; Chen YC; Wang AP
    J Wound Care; 2013 May; 22(5):244-7. PubMed ID: 23702721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effectiveness of larval therapy in the debridement of chronic wounds; a bibliographical review].
    Leyva-Moral JM
    Rev Enferm; 2007 Jan; 30(1):10-4. PubMed ID: 17380630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Maggot therapy with Lucilia sericata for debridement of chronic wounds].
    Cartier E; Combemale P
    Ann Dermatol Venereol; 2008 Oct; 135(10):685-8. PubMed ID: 18929922
    [No Abstract]   [Full Text] [Related]  

  • 15. Maximising the secondary beneficial effects of larval debridement therapy.
    Pritchard DI; Nigam Y
    J Wound Care; 2013 Nov; 22(11):610-11, 614-6. PubMed ID: 24225601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic applications of the larvae for wound debridement.
    Turkmen A; Graham K; McGrouther DA
    J Plast Reconstr Aesthet Surg; 2010 Jan; 63(1):184-8. PubMed ID: 19131291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients.
    Gilead L; Mumcuoglu KY; Ingber A
    J Wound Care; 2012 Feb; 21(2):78, 80, 82-85. PubMed ID: 22584527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor.
    Linger RJ; Belikoff EJ; Yan Y; Li F; Wantuch HA; Fitzsimons HL; Scott MJ
    BMC Biotechnol; 2016 Mar; 16():30. PubMed ID: 27006073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of maggot therapy on minimally necrotic tissues: characterization of larval enzymatic excretion/secretion].
    Téllez GA; Acero MA; Pineda LA; Castaño JC
    Biomedica; 2012 Sep; 32(3):312-20. PubMed ID: 23715180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maggots as a wound debridement agent for chronic venous leg ulcers under graduated compression bandages: A randomised controlled trial.
    Davies CE; Woolfrey G; Hogg N; Dyer J; Cooper A; Waldron J; Bulbulia R; Whyman MR; Poskitt KR
    Phlebology; 2015 Dec; 30(10):693-9. PubMed ID: 25300315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.